These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 30604869)

  • 1. Clindamycin alone may be enough. Is it time to abandon rifampicin for hidradenitis suppurativa? Reply from the authors.
    Albrecht J; Barbaric J; Nast A
    Br J Dermatol; 2019 May; 180(5):1262-1263. PubMed ID: 30604869
    [No Abstract]   [Full Text] [Related]  

  • 2. Rifampicin alone may be enough: is it time to abandon the classic oral clindamycin-rifampicin combination for hidradenitis suppurativa?
    Albrecht J; Barbaric J; Nast A
    Br J Dermatol; 2019 Apr; 180(4):949-950. PubMed ID: 30430552
    [No Abstract]   [Full Text] [Related]  

  • 3. Clindamycin alone may be enough. Is it time to abandon rifampicin for hidradenitis suppurativa?
    Caposiena Caro RD; Bianchi L
    Br J Dermatol; 2019 May; 180(5):1262. PubMed ID: 30604861
    [No Abstract]   [Full Text] [Related]  

  • 4. Prolonged clindamycin and rifampicin for hidradenitis suppurativa: resist to prevent resistance.
    Hambly R; Kirby B
    Br J Dermatol; 2019 Apr; 180(4):702-703. PubMed ID: 30933345
    [No Abstract]   [Full Text] [Related]  

  • 5. Clindamycin versus clindamycin plus rifampicin in hidradenitis suppurativa treatment: Clinical and ultrasound observations.
    Caposiena Caro RD; Cannizzaro MV; Botti E; Di Raimondo C; Di Matteo E; Gaziano R; Bianchi L
    J Am Acad Dermatol; 2019 May; 80(5):1314-1321. PubMed ID: 30502416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term clinical safety of clindamycin and rifampicin combination for the treatment of hidradenitis suppurativa: a strategy to reduce side-effects, improving patients' compliance.
    Marasca C; Masarà A; Annunziata MC; Bettoli V; Luciano MA; Fabbrocini G
    Br J Dermatol; 2019 Apr; 180(4):949. PubMed ID: 30430549
    [No Abstract]   [Full Text] [Related]  

  • 7. Clindamycin and rifampicin combination therapy for hidradenitis suppurativa.
    Mendonça CO; Griffiths CE
    Br J Dermatol; 2006 May; 154(5):977-8. PubMed ID: 16634904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymecycline vs. clindamycin plus rifampicin in hidradenitis suppurativa treatment: clinical and ultrasonography evaluation.
    Caposiena Caro RD; Molinelli E; Brisigotti V; Offidani A; Bianchi L
    Clin Exp Dermatol; 2021 Jan; 46(1):96-102. PubMed ID: 32683727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rifampicin and clindamycin for hidradenitis.
    Wall D; Kirby B
    J Am Acad Dermatol; 2011 Apr; 64(4):790. PubMed ID: 21414503
    [No Abstract]   [Full Text] [Related]  

  • 10. Effectiveness of clindamycin and rifampicin combination therapy in hidradenitis suppurativa: a 6-month prospective study.
    Yao Y; Jørgensen AR; Ring HC; Thomsen SF
    Br J Dermatol; 2021 Mar; 184(3):552-553. PubMed ID: 33000461
    [No Abstract]   [Full Text] [Related]  

  • 11. Oral ofloxacin and clindamycin as an alternative to the classic rifampicin-clindamycin in hidradenitis suppurativa: retrospective analysis of 65 patients.
    Delaunay J; Villani AP; Guillem P; Tristan A; Boibieux A; Jullien D
    Br J Dermatol; 2018 Jan; 178(1):e15-e16. PubMed ID: 28626900
    [No Abstract]   [Full Text] [Related]  

  • 12. Oral clindamycin and rifampicin combination therapy for hidradenitis suppurativa: a prospective study and 1-year follow-up.
    Dessinioti C; Zisimou C; Tzanetakou V; Stratigos A; Antoniou C
    Clin Exp Dermatol; 2016 Dec; 41(8):852-857. PubMed ID: 27753139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term clinical safety of clindamycin and rifampicin combination for the treatment of hidradenitis suppurativa. A Critically Appraised Topic.
    Albrecht J; Baine PA; Ladizinski B; Jemec GB; Bigby M
    Br J Dermatol; 2019 Apr; 180(4):749-755. PubMed ID: 30281779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clostridium difficile arising in a patient with hidradenitis suppurativa on clindamycin and rifampin.
    Bessaleli E; Scheinfeld N
    Dermatol Online J; 2018 May; 24(5):. PubMed ID: 30142743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of hidradenitis suppurativa with rifampicin: have we forgotten tuberculosis?
    Mendes-Bastos P; Macedo R; Duarte R
    Br J Dermatol; 2017 Oct; 177(4):e150-e151. PubMed ID: 28718933
    [No Abstract]   [Full Text] [Related]  

  • 16. The efficacy and tolerability of tetracyclines and clindamycin plus rifampicin for the treatment of hidradenitis suppurativa: Results of a prospective European cohort study.
    van Straalen KR; Tzellos T; Guillem P; Benhadou F; Cuenca-Barrales C; Daxhelet M; Daoud M; Efthymiou O; Giamarellos-Bourboulis EJ; Jemec GBE; Katoulis AC; Koenig A; Lazaridou E; Marzano AV; Matusiak Ł; Molina-Leyva A; Moltrasio C; Pinter A; Potenza C; Romaní J; Saunte DM; Skroza N; Stergianou D; Szepietowski J; Trigoni A; Vilarrasa E; van der Zee HH
    J Am Acad Dermatol; 2021 Aug; 85(2):369-378. PubMed ID: 33484766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Why rifampin (rifampicin) is a key component in the antibiotic treatment of hidradenitis suppurativa: a review of rifampin's effects on bacteria, bacterial biofilms, and the human immune system.
    Scheinfeld N
    Dermatol Online J; 2016 Jun; 22(6):. PubMed ID: 27617596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. KITTEN following CAT on the long-term use of rifampicin in hidradenitis suppurativa and effectiveness of oral contraceptives.
    Yazdanyar S; Jemec GB
    Br J Dermatol; 2019 Jul; 181(1):225-226. PubMed ID: 30907428
    [No Abstract]   [Full Text] [Related]  

  • 19. Dramatic reduction of clindamycin plasma concentration in hidradenitis suppurativa patients treated with the rifampin-clindamycin combination.
    Join-Lambert O; Ribadeau-Dumas F; Jullien V; Kitzis MD; Jais JP; Coignard-Biehler H; Guet-Revillet H; Consigny PH; Delage M; Nassif X; Lortholary O; Nassif A
    Eur J Dermatol; 2014; 24(1):94-5. PubMed ID: 24445967
    [No Abstract]   [Full Text] [Related]  

  • 20. Interruption of oral clindamycin plus rifampicin therapy in patients with hidradenitis suppurativa: An observational study to assess prevalence and causes.
    Schneller-Pavelescu L; Vergara-de Caso E; Martorell A; Romaní J; Lázaro M; Vilarrasa E; Díaz-Ley B; Vázquez-Osorio I; Segura Palacios JM; Azaña JM; González-López MA; Cañueto J; Molina-Leyva A; Leiva-Salinas M; Navarro-Triviño FJ; Sánchez-Payá J; Pascual JC
    J Am Acad Dermatol; 2019 May; 80(5):1455-1457. PubMed ID: 30630028
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.